Goldman Sachs upgraded MetLife to Buy from Neutral with an $80 price target. While concerns around Metlife’s real estate exposure weighed on the stock in 2023, the core business has continued to perform well and its capital position has been significantly strengthened, the analyst tells investors in a research note. In 2024, the firm sees easing headwinds from the weaker 2023 alternative investment returns and suspects the strength of MetLife’s organic growth and consistent businesses will be more of a focal point for investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MET:
- MetLife price target lowered to $81 from $82 at JPMorgan
- MetLife price target raised to $78 from $73 at Piper Sandler
- MetLife CFO says ‘quality will win out in every class of real estate’
- 5 Top Financial Stocks to Buy Now, According to Analysts – November 2023
- Airbnb downgraded, Expedia upgraded: Wall Street’s top analyst calls